Published in Cancer Weekly, July 26th, 2005
"We studied the inverse relationship between HER-2 and estrogen (ER) and progesterone (PR) receptors using HER-2 testing and correlated HER-2 status with histologic features in 3,655 unselected invasive breast carcinomas.
"Immunohistochemical analysis for ER, PR, HER-2, and fluorescence in situ hybridization for HER-2 was performed," researchers in the United States report.
"ER and PR expression were decreased...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.